WACKER Replaces Coal with Biogenic Carbon for Climate-Neutral Silicon Production WACKER, a global leader in the production of high-purity silicones and silicon-based products, is embarking on an important sustainability milestone by replacing fossil coal with biogenic carbon in its silicon…
Global Chemical Public Company Limited Becomes First Chemical Producer to Utilize U.S. Ethane Imports in Thailand Introduction: A Groundbreaking Strategic Move PTT Global Chemical Public Company Limited, a prominent player in the global chemical industry, is making history by becoming…
Allosteric Bioscience, Inc. Partners with Johns Hopkins to Combat Sarcopenia Addressing Sarcopenia: A Growing Global Concern Allosteric Bioscience, Inc. is tackling this issue head-on by announcing the licensing of a groundbreaking technology from Johns Hopkins University aimed at treating and…
Trestle Bio Partners with Humacyte to Advance Bioengineered Kidney Research Trestle Biotherapeutics, Inc., a company dedicated to developing bioengineered kidney tissues for patients with end-stage renal disease (ESRD), has announced a significant research collaboration with Humacyte, Inc. Humacyte, a commercial-stage…
Aerospace & Life Sciences Testing, Inspection, and Certification Market Overview has been added to ResearchAndMarkets.com’s offering. The global market for Aerospace & Life Sciences Testing, Inspection, and Certification (TIC) services is expected to grow significantly in the coming years. Valued at approximately…
Draslovka Partners with Natron Energy to Advance Sodium-Ion Battery Production Introduction to the Partnership Draslovka a.s., a global leader in sustainability-driven technologies, reagents, and services for the mining and energy transition sectors, has entered into a strategic partnership with Natron…
QIAGEN Receives U.S. FDA Clearance for Second QIAstat-Dx Mini Gastrointestinal Panel QIAGEN has announced that the U.S. Food and Drug Administration (FDA) has granted clearance for its QIAstat-Dx Gastrointestinal Panel 2 Mini B, marking a significant milestone in the company’s…
ENCell’s EN001 Receives FDA Orphan Drug Designation for Charcot-Marie-Tooth Disease ENCell, a leading biopharmaceutical company specializing in cell and gene therapy, has announced that its investigational drug, EN001, has been granted Orphan Drug Designation (ODD) by the U.S. Food and…
Colorado BioScience Association Welcomes Four New Leaders to Board of Directors The Colorado BioScience Association has announced the appointment of four new accomplished leaders to its Board of Directors, a move that further strengthens the organization’s efforts to enhance it’s…
Promega Sues Aobious for Patent Infringement Over Furimazine Substrates Promega Corporation, a global leader in biotechnology tools, announced that it has filed a patent infringement lawsuit against Aobious, Inc. The lawsuit, filed in the U.S. District Court for the District…
TRIMTECH Therapeutics Secures $31M in Seed Funding to Advance Targeted Protein Degradation Treatments for Neurodegenerative Diseases TRIMTECH Therapeutics, a biotech company focused on developing therapies using targeted protein degradation (TPD) for neurodegenerative diseases, has announced the successful completion of its…
Atwell Gives Foundation Partners with Science Olympiad to Expand STEM Opportunities The Atwell Gives Foundation has launched a new national partnership with Science Olympiad, one of the largest and most well-known STEM (science, technology, engineering, and math) team competitions in…